FDA
-
-
-
-
-
-
-
Dogwood Therapeutics receives FDA acceptance for SP16 pain treatment trial
-
-
-
-
-
-
-
Dogwood Therapeutics reports positive interim data for pain drug
-
-
-
-
-
-
-
Dogwood Therapeutics licenses SP16 for cancer pain treatment
-
-
-
-
-
-
-
Dogwood Therapeutics to Present at Sidoti Small-Cap Virtual Conference
-
-
-
-
-
-
-
Dogwood Therapeutics, Inc. Regains Nasdaq Compliance
-
-
-
-
-
-
-
Dogwood Therapeutics, Inc. Announces Conversion of Existing $19.5M in Debt to Equity, Strengthening Balance Sheet Moving Forward
-
-
-
-
-
-
322,915 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

